Drug-induced hypersensitivity syndrome associated with a marked increase in anti-paramyxovirus antibody titers in a scleroderma patient

Allergology International

Volumn 56, Issue 3, 2007, Pages 303-308

  Naniwa, Taio ^a   Maeda, Shinji ^a   Sawada, Hiroo ^b   Watanabe, Yuko ^a   Osawa, Tomoyo ^a   Hayami, Yoshihito ^a   Banno, Shogo ^a   Morita, Akimichi ^a   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Inabe General Hospital   (Japan)

Author keywords

Cyclophosphamide; Drug hypersensitivity; Mumps virus; Parainfluenza virus; Sulfamethoxazole trimethoprim

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; VIRUS ANTIBODY;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CASE REPORT; COMMON COLD; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHIL COUNT; EOSINOPHILIA; ERYTHEMA; FEVER; HUMAN; INTERSTITIAL PNEUMONIA; LOW DRUG DOSE; LYMPHOCYTIC INFILTRATION; MALE; MUMPS VIRUS; MYOSITIS; PARAINFLUENZA VIRUS 2; PARAMYXOVIRUS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RNA VIRUS INFECTION; SCLERODERMA; SKIN BIOPSY; VIROLOGY;

EID: 34548851941     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.C-06-49     Document Type: Article

References (29)

1. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 1994;331:1272-1285.
2. Suzuki Y, Inagi R, Aono T et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch. Dermatol. 1998;134:1108-1112.
3. Tohyama M, Yahata Y, Yasukawa M et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch. Dermatol. 1998;134:1113-1117.
4. Hicks ME, Smith CL, Stein GE. Trimethoprim/ sulfamefhoxazole-induced hypersensitivity syndrome. Ann. Pharmacother. 1997;31:1259.
5. Mainra RR, Card SE. Trimethoprim-sulfamethoxazole-associated hepatotoxiciry - part of a hypersensitivity syndrome. Can. J. Clin. Pharmacol. 2003;10:175-178.
6. Morimoto T, Sato T, Matsuoka A et al. Trimethoprimsulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6. Intern. Med. 2006;45:101-105.
7. Descamps V, Mahe E, Houhou N et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br. J. Dermatol. 2003;148:1032-1034.
8. Aihara M, Sugita Y, Takahashi S et al. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br. J. Dermatol. 2001;144:1231-1234.
9. Lamb RA, Kolakofsky D. Paramyxoviridae: The Viruses and Their Replication. In: Knipe DM, Howley PM (eds). Fields Virology. 4th edn. Vol. 1. Philadelphia: Lippincott Williams & Wilkins, 2001;1305-1340.
10. Carbone KM, Wolinsky JS. Mumps Virus. In: Knipe DM, Howley PM, (eds). Fields Virology. 4th edn. Vol. 1. Philadelphia: Lippincott Williams & Wilkins, 2001; 1381-1400.
11. Tanabayashi K, Takeuchi K, Hishiyama M et al. Nucleotide sequence of the leader and nucleocapsid protein gene of mumps virus and epitope mapping with the in vitro expressed nucleocapsid protein. Virology 1990;177: 124-130.
12. Descamps V, Valance A, Edlinger C et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch. Dermatol. 2001;137:301-304.
13. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch. Dermatol. 2001; 137:357-364.
14. Mitani N, Aihara M, Yamakawa Y et al. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J. Med. Virol. 2005;75:430-434.
15. Hashizume H, Takigawa M. Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Derm. Venereol. 2005;85:47-50.
16. Rotunda A, Hirsch RJ, Scheinfeld N et al. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm. Venereol. 2003;83:1-9.
17. Regnier S, Descamps V, Boui M et al. Parvovirus B19 infection mimicking drug-induced hypersensitivity syndrome. Ann. Dermatol. Venereol. 2000;127:505-506.
18. Kosseian-Bal I, Bocquet H, Beneton N et al. Hypersensitivity syndrome during Mycoplasma pneumoniae infection. Ann. Dermatol. Venereol. 1998;125:328-330.
19. Huppertz HI, Chantler JK. Restricted mumps virus infection of cells derived from normal human joint tissue. J. Gen. Virol. 1991;72 (Pt 2):339-347.
20. Hariya Y, Shirakawa S, Yonekura N et al. Augmentation of verotoxin-induced cytotoxicity/apoptosis by interferon is repressed in cells persistently infected with mumps virus. J. Interferon. Cytokine Res. 1999;19:479-485.
21. Shiohara T, Inaoka M, Kano Y. Drug-induced Hypersensitivity Syndrome (DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune Responses. Allergol. Int. 2006;55:1-8.
22. Chanock RM, Murphy BR, Collins PL. Parainfluenza Viruses. In: Knipe DM, Howley PM, (eds). Fields Virology. 4th edn. Vol. 1. Philadelphia: Lippincott Williams & Wilkins, 2001;1341-1379.
23. Steen VD, Medsger TA Jr. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum. 1998;41:1613-1619.
24. Naniwa T, Banno S, Takahashi N et al. Normotensive scleroderma renal crisis with diffuse alveolar damage after corticosteroid therapy. Mod. Rheumatol. 2005;15:134-138.
25. Abou-Donia H, Jennings R, Potter CW. The spread and persistence of influenza viruses in normal and cyclophosphamide-treated mice. J. Med. Virol. 1981;7:251-262.
26. Alonso CM, Lozada CJ. Effects of IV cyclophosphamide on HIV viral replication in a patient with systemic lupus erythematosus. Clin. Exp. Rheumatol. 2000;18:510-512.
27. Su YC, Rolph MS, Cooley MA et al. Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease. J. Allergy Clin. Immunol. 2006;117:635-641.
28. Smith DR, Balashov KE, Hafler DA et al. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia. Ann. Neurol. 1997;42:313-318.
29. Karni A, Balashov K, Hancock WW et al. Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis. J. Neuroimmunol. 2004;146:189-198.